ReVascular Therapeutics was acquired by Boston Scientific on February 15, 2011

Medical Products Company

Out of 60 sectors in the Mergr database, medical products ranked 10 in number of deals in 2011. The largest medical products acquisition in 2011 was Synthes - which was acquired by Johnson & Johnson for $19.3B.

Join Mergr to view all 177 acquisitions of medical products companies in 2011, including 31 acquisitions by private equity firms, and 146 by strategics.

ReVascular Therapeutics, Inc.

766 Palomar Avenue,
Sunnyvale, California 94085
United States,
(408) 617-0770

Revascular Therapeutics, Inc. operates as an arterial occlusion treatment company. It develops percutaneous medical devices to reopen occluded vessels. The company develops technology for the intravascular treatment of complex lesions and total occlusions. Revascular Therapeutics, Inc. was incorporated in 1999 and is headquartered in Sunnyvale, California.


 Subscribe to unlock this and 163,777
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.1K Private Equity Firms
  • 152K M&A Transactions
  • 160K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.2K M&A Advisors
    (Investment Banks and Law Firms)
  • 49K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.